Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test may unlock clotting secrets in burn injuries

NCT ID NCT06879509

Terminated Knowledge-focused Sponsor: Francesco Egro Source: ClinicalTrials.gov ↗

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This pilot study is testing whether a specialized blood test called thromboelastography (TEG) can better evaluate clotting problems in people with severe burns. Researchers will track clotting patterns over the first four weeks after injury and see if they relate to burn size or predict complications. The goal is to improve how doctors monitor and treat clotting issues in burn patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
thromboelastography (TEG) blood test
What this could lead to
If successful, this could lead to better ways to monitor and treat clotting issues in burn patients, potentially improving recovery and reducing complications.
What could go wrong
This is a small pilot study, so results may not apply to all burn patients. The test is exploratory and may not clearly predict outcomes or guide treatment changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BURN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

blood coagulation disease burn thrombotic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BURN COAGULATION, BLOOD

Contacts and locations

Locations

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, 15219, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.